cbdMD (YCBD) EPS (Weighted Average and Diluted): 2017-2024
Historic EPS (Weighted Average and Diluted) for cbdMD (YCBD) over the last 4 years, with Jun 2024 value amounting to -$0.15.
- cbdMD's EPS (Weighted Average and Diluted) rose 87.07% to -$0.15 in Q2 2024 from the same period last year, while for Jun 2024 it was -$5.68, marking a year-over-year decrease of 3.27%. This contributed to the annual value of -$0.47 for FY2021, which is 267.86% down from last year.
- Per cbdMD's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.15 for Q2 2024, which was up 77.94% from -$0.68 recorded in Q1 2024.
- cbdMD's 5-year EPS (Weighted Average and Diluted) high stood at $0.40 for Q1 2020, and its period low was -$3.69 during Q1 2023.
- Over the past 3 years, cbdMD's median EPS (Weighted Average and Diluted) value was -$0.61 (recorded in 2022), while the average stood at -$1.05.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first spiked by 112.78% in 2020, then plummeted by 3,590.00% in 2023.
- Quarterly analysis of 5 years shows cbdMD's EPS (Weighted Average and Diluted) stood at -$0.18 in 2020, then crashed by 94.44% to -$0.35 in 2021, then tumbled by 2,850.00% to -$0.55 in 2022, then crashed by 110.91% to -$1.16 in 2023, then soared by 87.07% to -$0.15 in 2024.
- Its EPS (Weighted Average and Diluted) was -$0.15 in Q2 2024, compared to -$0.68 in Q1 2024 and -$1.16 in Q2 2023.